Viewing Study NCT04246359


Ignite Creation Date: 2025-12-24 @ 2:32 PM
Ignite Modification Date: 2026-01-09 @ 8:48 AM
Study NCT ID: NCT04246359
Status: UNKNOWN
Last Update Posted: 2022-04-07
First Post: 2020-01-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Rituximab and Pegylated Interferon α-2b in Patients With Indolent B-cell Lymphoma
Sponsor: Huiqiang Huang
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, B-Cell View
Keywords:

Keywords

Keyword Brief Keyword Text View
None indolent B-cell lymphoma View
None Rituximab(HLX01) View
None Pegylated Interferon α-2b View
None HBsAg clearance rate View